| 发明名称 |
USE OF BUBR1 AS A BIOMARKER OF DRUG RESPONSE TO FURAZANOBENZIMIDAZOLES |
| 摘要 |
Use of BUBR1 as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject, wherein the compound is a furazanobenzimidazole compound of general formula (I). |
| 申请公布号 |
EP2666016(B1) |
申请公布日期 |
2017.01.04 |
| 申请号 |
EP20120701341 |
申请日期 |
2012.01.19 |
| 申请人 |
Basilea Pharmaceutica AG |
发明人 |
LANE, Heidi Alexandra;BACHMANN, Felix;BREULEUX, Madlaina;BOUTROS, Michael;GILBERT, Daniel;ZHANG, Xian |
| 分类号 |
G01N33/50;A61K31/4245;A61K31/4439;C12Q1/68;G01N33/574 |
主分类号 |
G01N33/50 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
